Cmpx stock forecast.
The consensus estimate for Capital Power’s current full-year earnings is $3.23 per share. Raymond James also issued estimates for Capital Power’s Q2 2024 earnings at $0.89 EPS, Q3 2024 earnings at $1.61 EPS, Q4 2024 earnings at $1.17 EPS and FY2024 earnings at $5.27 EPS. Several other research analysts have also weighed in on the stock.
The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]Compass Therapeutics Inc. (CMPX) stock is trading at $3.76 as of 3:42 PM on Friday, Jan 20, a gain of $0.01, or 0.27% from the previous closing price of $3.75. Volume today is above average. So far 918,164 shares have traded compared to average volume of 271,877 shares. The stock has traded between $3.20 and $3.88 so far today.CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.Get the latest news and real-time alerts from Compass Therapeutics, Inc. (CMPX) stock at Seeking Alpha. ... CMPX Compass Therapeutics, Inc. Latest News. Follow $1.93 0.00 (0.00%) ...
Nov 29, 2023 · CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%.
As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.
Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.Predictions of CMPX stock price for tomorrow.$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …
Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase …
Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.
The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in …GLTO Stock 12 Months Forecast. $5.67. (808.65% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Galecto in the last 3 months. The average price target is $5.67 with a high forecast of $10.00 and a low forecast of $2.00. The average price target represents a 808.65% change from the last price of $0.62.SCYX Stock 12 Months Forecast. $11.25. (555.98% Upside) Based on 3 Wall Street analysts offering 12 month price targets for SCYNEXIS in the last 3 months. The average price target is $11.25 with a high forecast of $15.00 and a low forecast of $7.50. The average price target represents a 555.98% change from the last price of $1.71.Abstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), and …All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...
Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.According to . 4 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $57.25, with the highest CMPS stock price forecast at $120.00 and the lowest CMPS stock price forecast at $21.00. The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors?Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ...Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...Leader in personal finance news and business forecasting. Get trusted advice on investing, retirement, taxes, saving, real estate, cars, college, insurance.CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.
The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …Watch live market analysis and forecasts, learn new trading strategies, share your ideas and opinions with millions of traders with our streams.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Get the latest CompX International Inc. (CIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.c1968 kd 99121 57/64 bolt type lock 1k-compx stock locksNov 23, 2022 · Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ... The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low.
10% most volatile stocks in GB Market. 12.0%. 10% least volatile stocks in GB Market. 2.6%. Stable Share Price: CPX is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: CPX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of UK stocks.
Their CMPX share price targets range from $8.00 to $10.30. On average, they anticipate the company's stock price to reach $9.33 in the next year. This suggests a possible upside of 509.5% from the stock's current price. View analysts price targets for …
Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyFuture criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.Compx International Inc: A High-Performing Stock with a GF Score of 93. GF Score analysis. Find the latest CompX International Inc. (CIX) stock quote, history, news and other vital information to ... Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase …Dec 1, 2023 · The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? Meta Materials, Inc. engages in the manufacture and development of functional materials. Its technology platform enables global brands to deliver products to customers in consumer electronics, 5G ...Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase …
GTHX Stock 12 Months Forecast. $9.00. (429.41% Upside) Based on 3 Wall Street analysts offering 12 month price targets for G1 Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 429.41% change from the last price of $1.70.Comprehensive selection of real-time charts, which plot movements in the forex, futures and stock markets, with quotes updated continuously throughout the trading day.Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ...Instagram:https://instagram. des etfthorne healthtech stockark innovation etf holdingsis forex.com good Find the latest performance data chart, historical data and news for NASDAQ Composite Index (COMP) at Nasdaq.com.PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62. what is an exchange funddis chem Nov 30, 2023 · The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period. Check if CMPS Stock has a Buy or Sell Evaluation. CMPS Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Compass Pathways PLC News. forex robot trading Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CompX International Inc have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The ...Stock Market Today: Stocks extend gains as investors ignore Powell warning on rates. Investors are heading into the final month of the year on solid footing, with an 18.5% gain for the S&P 500 and ...BHC Stock 12 Months Forecast. $9.00. (30.72% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $9.00 with a high forecast of $16.00 and a low forecast of $6.00. The average price target represents a 30.72% change from the last price of $6.89.